advertisement
 |
|
Top Pharmaceutical Technology News Stories of 2018 |
|
|
Bayer completed its acquisition of Monsanto, the largest in Bayer's history.
/ read more /
Westminster Pharmaceuticals, LLC is voluntarily recalling Levothyroxine and Liothyronine (Thyroid Tablets, USP) after FDA issues import alert affecting the active ingredient.
/ read more /
FDA testing has found an additional impurity, N-Nitrosodiethylamine, in the API valsartan.
/ read more /
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
/ read more /
FDA sent a warning letter to Goran Pharma Private Limited citing inadequate quality control violations.
/ read more /
Takeda expands its global and therapy base with announced acquisition of Shire.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
Fresenius Kabi claims that Akorn failed to fulfill several closing conditions.
/ read more /
The agency clarifies recommendations found in ICH Q11 about chemical entities and biotechnology entities.
/ read more /
FDA sent a warning letter to Lijiang Yinghua Biochemical and Pharmaceutical Co., Ltd. for failure to follow current good manufacturing practices.
/ read more /
The acquisition is expected to strengthen Sanofi's R&D strategy with Ablynx's nanobody technology platform.
/ read more /
|
|
|
Top Pharmaceutical Technology Feature Stories of 2018 |
|
|
This article describes a new, combined, quantitative method for assessing excipient risks that has been developed by the authors as one possible risk evaluation method.
/ read more /
New technologies, such as NIR and Raman, enable online measurements of blending and content uniformity in the production of solid dosage forms.
/ read more /
The pharmaceutical industry is adopting Industry 4.0 and emerging technologies to improve product quality and manufacturing efficiency.
/ read more /
This article focuses on applying new and traditional techniques to design a cleaning process, ensure the surfaces are clean, and develop rinse solution analysis to continuously monitor cleaning performance.
/ read more /
The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
/ read more /
|
|
|
Airflow visualization studies, or smoke studies, confirm unidirectional airflow patterns in an aseptic processing facility.
/ read more /
Pharma 4.0 envisions highly efficient automated processes, which could be continuous, batch, or a hybrid of these, driven by an integrated manufacturing control strategy.
/ read more /
Determining the right process conditions for a freeze-drying cycle requires an understanding of the effect of each step on the drug product.
/ read more /
Taking vendor product data at face value puts pharmaceutical manufacturers and their supply chain partners at risk.
/ read more /
The flexibility and incompatibility of ICH Q12 guidelines with current EU legislations raise complications.
/ read more /
|
|
|
Events
February 6–7, 2019
March 3–6, 2019
March 11–13, 2019
more events |
|
|
eBOOKS
 |
The editors explore new tools for bio/pharma lab studies—such as robotics, augmented reality, and advanced instrumentation— as well as best practices for method development, multiple attribute monitoring, lab mixers, and raw material testing. |
|
|
|
|
|